California Public Employees Retirement System
IOVA icon

California Public Employees Retirement System’s Iovance Biotherapeutics IOVA Stock Holding History

California Public Employees Retirement System’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-271,534
Closed -$3M – 1232
2022
Q2 		$3M Sell
271,534
-19,585
-7% -$257K ﹤0.01% 1146
2022
Q1 		$4.85M Sell
291,119
-4,296
-1% -$66.4K ﹤0.01% 1138
2021
Q4 		$5.64M Hold
295,415
– – ﹤0.01% 1147
2021
Q3 		$7.29M Sell
295,415
-4,405
-1% -$104K 0.01% 1127
2021
Q2 		$7.8M Sell
299,820
-15,858
-5% -$412K 0.01% 1140
2021
Q1 		$9.99M Sell
315,678
-19,007
-6% -$788K 0.01% 1075
2020
Q4 		$15.5M Buy
334,685
+19,823
+6% +$787K 0.01% 770
2020
Q3 		$10.4M Buy
314,862
+12,717
+4% +$390K 0.01% 829
2020
Q2 		$8.29M Buy
302,145
+41,161
+16% +$1.35M 0.01% 907
2020
Q1 		$7.81M Sell
260,984
-52,300
-17% -$1.39M 0.01% 801
2019
Q4 		$8.67M Buy
313,284
+8,761
+3% +$199K 0.01% 1061
2019
Q3 		$5.54M Buy
304,523
+70,423
+30% +$1.56M 0.01% 1234
2019
Q2 		$5.74M Sell
234,100
-31,500
-12% -$474K 0.01% 1039
2019
Q1 		$2.53M Sell
265,600
-20,840
-7% -$202K ﹤0.01% 1622
2018
Q4 		$2.54M Buy
286,440
+187,900
+191% +$1.81M ﹤0.01% 1550
2018
Q3 		$1.11M Sell
98,540
-6,900
-7% -$97.9K ﹤0.01% 2271
2018
Q2 		$1.35M Buy
105,440
+5,598
+6% +$81.8K ﹤0.01% 2159
2018
Q1 		$1.69M Buy
+99,842
New +$1.51M ﹤0.01% 1993

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Pictet Asset Management (Switzerland)
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

California Public Employees Retirement System's IOVA Position: Q3 2022 in Review

California Public Employees Retirement System sold out of Iovance Biotherapeutics (IOVA) in Q3 2022, closing a stake of 271,534 shares — an estimated $3M sold.

California Public Employees Retirement System first reported a position in IOVA in Q1 2018 and held it in 18 quarters. The position peaked at $15.5M in Q4 2020. 242 funds tracked by Wall St. Rank hold IOVA as of Q3 2022.

  • California Public Employees Retirement System reported no remaining Iovance Biotherapeutics position as of Q3 2022 after selling out during the quarter.
  • California Public Employees Retirement System sold 271,534 Iovance Biotherapeutics shares in Q3 2022, an estimated $3M.
  • California Public Employees Retirement System first reported a position in Iovance Biotherapeutics in Q1 2018 and held it in 18 quarters.
  • California Public Employees Retirement System's Iovance Biotherapeutics position peaked at $15.5M in Q4 2020.
  • 242 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2022.

Based on California Public Employees Retirement System's 13F filing for Q3 2022, filed 9 Nov 2022.